| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11255-015-1022-0 |
| P8608 | Fatcat ID | release_im72kxcouff6lau6j6g5ogqkvq |
| P698 | PubMed publication ID | 26047596 |
| P5875 | ResearchGate publication ID | 277777549 |
| P2093 | author name string | Sumeyye Gullulu | |
| Alparslan Ersoy | |||
| Cuma Bulent Gul | |||
| Serdar Kahvecioglu | |||
| Saim Sag | |||
| Selime Ermurat | |||
| Mustafa Gullulu | |||
| Aysegul Oruc | |||
| Fatih Yildirim | |||
| Abdulmecit Yildiz | |||
| Burak Asiltas | |||
| P2860 | cites work | Autosomal dominant polycystic kidney disease: the last 3 years | Q24656249 |
| Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease | Q24657714 | ||
| A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group | Q29614889 | ||
| Neutrophil-to-lymphocyte ratio, insulin resistance, and endothelial dysfunction in patients with autosomal dominant polycystic kidney disease | Q30455487 | ||
| Coronary flow velocity reserve and carotid intima media thickness in patients with autosomal dominant polycystic kidney disease: from impaired tubules to impaired carotid and coronary arteries | Q30488508 | ||
| Relationship between arterial elasticity indices and carotid artery intima-media thickness | Q33181455 | ||
| Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? | Q33345061 | ||
| Structural and functional vascular alterations and incident hypertension in normotensive adults: the Multi-Ethnic Study of Atherosclerosis | Q33566795 | ||
| Polycystic kidney disease | Q33709685 | ||
| Hypertension in autosomal-dominant polycystic kidney disease: early occurrence and unique aspects | Q34116421 | ||
| Genetics and pathogenesis of polycystic kidney disease. | Q34145624 | ||
| Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study | Q34150807 | ||
| Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility | Q34403569 | ||
| Elevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction. | Q34713240 | ||
| Uric acid and pentraxin-3 levels are independently associated with coronary artery disease risk in patients with stage 2 and 3 kidney disease | Q34724967 | ||
| Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes | Q34751855 | ||
| Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis | Q35133148 | ||
| Hypertension and left ventricular hypertrophy in autosomal dominant polycystic kidney disease | Q35777393 | ||
| Inflammation in end-stage renal disease: the hidden enemy | Q36410507 | ||
| Associations between arterial elasticity and markers of inflammation in healthy older women. | Q36672175 | ||
| Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease | Q36736700 | ||
| Vascular stiffness: its measurement and significance for epidemiologic and outcome studies | Q37051985 | ||
| Relations of measures of endothelial function and kidney disease: the Framingham Heart Study | Q37150714 | ||
| Endothelial dysfunction occurs prior to clinical evidence of polycystic kidney disease | Q37329086 | ||
| Inflammation in end-stage renal disease--what have we learned in 10 years? | Q37805641 | ||
| Pentraxin 3 as a novel bio-marker of inflammation and endothelial dysfunction in autosomal dominant polycystic kidney disease. | Q39252622 | ||
| Prognostic impact of arterial stiffness in patients with symptomatic peripheral arterial disease. | Q43503526 | ||
| The relationship between neutrophil-to-lymphocyte ratio and inflammation in end-stage renal disease patients | Q43746428 | ||
| Reduced small artery but not large artery elasticity is an independent risk marker for cardiovascular events | Q44387212 | ||
| Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality | Q44571381 | ||
| Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal-dominant polycystic kidney disease | Q44581660 | ||
| The relationship between neutrophil-to-lymphocyte ratio and vascular calcification in end-stage renal disease patients | Q44823892 | ||
| Insulin resistance and coronary flow velocity reserve in patients with autosomal dominant polycystic kidney disease | Q47857979 | ||
| A comparison between systolic and diastolic pulse contour analysis in the evaluation of arterial stiffness | Q49062693 | ||
| Endothelial dysfunction and low-grade inflammation are associated with greater arterial stiffness over a 6-year period. | Q51538168 | ||
| First- and third-order models for determining arterial compliance | Q52417051 | ||
| The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality. | Q53496784 | ||
| 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). | Q55057254 | ||
| Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: contribution of extrarenal complications to mortality | Q74567948 | ||
| Pulse wave reflection is amplified in normotensive patients with autosomal-dominant polycystic kidney disease and normal renal function | Q80050909 | ||
| Pentraxin 3 is elevated in haemodialysis patients and is associated with cardiovascular disease | Q80316793 | ||
| C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease | Q80366069 | ||
| Early arterial stiffness and inflammatory bio-markers in normotensive polycystic kidney disease patients | Q84379418 | ||
| Arterial dysfunction in early autosomal dominant polycystic kidney disease independent of fibroblast growth factor 23 | Q85895711 | ||
| P433 | issue | 7 | |
| P921 | main subject | autosomal dominant polycystic kidney | Q2732398 |
| autosomal dominant polycystic kidney disease | Q15443105 | ||
| P304 | page(s) | 1187-1194 | |
| P577 | publication date | 2015-06-06 | |
| P1433 | published in | International Urology and Nephrology | Q15763616 |
| P1476 | title | Correlation between arterial stiffness and inflammatory markers in autosomal dominant polycystic kidney disease patients with preserved renal function | |
| P478 | volume | 47 |
Search more.